Financhill
Sell
19

APLS Quote, Financials, Valuation and Earnings

Last price:
$17.30
Seasonality move :
-4.83%
Day range:
$17.24 - $18.10
52-week range:
$16.65 - $43.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.78x
P/B ratio:
13.24x
Volume:
3M
Avg. volume:
3M
1-year change:
-59.31%
Market cap:
$2.2B
Revenue:
$781.4M
EPS (TTM):
-$1.79

APLS Analysts' Consensus Rating

The 20 analysts providing 12-month price projections for Apellis Pharmaceuticals shares anticipate an average target of $39.05, ranging from a low estimate of $18.00 to a high estimate of $75.00. This average target implies a growth of 125.71% compared to the current stock price of $17.30.

Consensus Price Target

$39.05

Highest Price Target

$75.00

Lowest Price Target

$18.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 11 12 12

Hold 7 8 8

Sell 0 0 0
Consensus Buy Buy Buy

APLS Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Spotify a Millionaire-Maker Stock?
Is Spotify a Millionaire-Maker Stock?

Spotify (NYSE:SPOT) may seem like an expensive proposition trading closer…

What Is a Millionaire-Maker Stock?
What Is a Millionaire-Maker Stock?

From time to time, investors will run across the term…

5 Investors to Follow Other Than Warren Buffett
5 Investors to Follow Other Than Warren Buffett

There is no doubt that Warren Buffett is one of…

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 40x

Alerts

Buy
60
RGC alert for May 10

Regencell Bioscience Holdings [RGC] is up 79.25% over the past day.

Buy
97
NGVC alert for May 10

Natural Grocers by Vitamin Cottage [NGVC] is up 30.26% over the past day.

Sell
38
ONTO alert for May 10

Onto Innovation [ONTO] is down 30.17% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock